Filing Details
- Accession Number:
- 0000899243-22-005408
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-09 15:56:04
- Reporting Period:
- 2022-02-07
- Accepted Time:
- 2022-02-09 15:56:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 749660 | Icad Inc | ICAD | Surgical & Medical Instruments & Apparatus (3841) | 020377419 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1515322 | Andy Sassine | C/O Icad Inc 98 Spit Brook Road, Suite 100 Nashua NH 03062 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-07 | 10,000 | $5.26 | 1,208,382 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-08 | 10,000 | $5.49 | 1,198,382 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, which provides for the sale of 20,000 shares eachmonth until August 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.17 to $5.40 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold by it at each separate price on February 7, 2022.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold by it at each separate price on February 8, 2022.
Billionaire Hedge Funds
